Author: Sande, Michiel A J : Search

Access byZhejiang Agr & For University

Zhejiang Agr & For University

15results for"Sande, Michiel A J" in Contributors

SAVE SEARCH

RSS

Filters

Date

Search Terms

Context Search Term

Select search in areaSearch Term

Published in

Publication Date

All Dates

LastSelect static range

Custom RangeSelect starting monthSelect starting year

Select ending monthSelect ending year

Search name	Searched On	Run search
Author: Chan, Anthony K C (42)	Aug 01 2025	Run
Author: Polizzotto, Mark N (23)	Aug 01 2025	Run
Author: Sande, Michiel A J (15)	Aug 01 2025	Run
Author: Luković, Nevena D (2)	Aug 01 2025	Run
Author: Heideman, Daniëlle A M (42)	Aug 01 2025	Run

You do not have any saved searches

Export Citation(s)Download PDF(s)

Original Article
Free Access

free

Outcome of advanced, unresectable conventional central chondrosarcoma

Annemiek M. van Maldegem MD, Hans Gelderblom MD, PhD, Emanuela Palmerini MD, Sander D. Dijkstra MD, PhD, Marco Gambarotti MD, Pietro Ruggieri MD, PhD, Remi A. Nout MD, PhD, Michiel A. J. van de Sande MD, PhD, Cristina Ferrari BSc, Stefano Ferrari MD, Judith V. M. G. Bovée MD, PhD, Piero Picci MD,

Cancer Volume 120, Issue 20
First published: 03 July 2014

Abstract
Original Article
Open Access

oa

Extrameningeal solitary fibrous tumors—surgery alone or surgery plus perioperative radiotherapy: A retrospective study from the global solitary fibrous tumor initiative in collaboration with the Sarcoma Patients EuroNet

Rick L. Haas MD, PhD, Iris Walraven MD, PhD, Estelle Lecointe-Artzner MD, PhD, Winan J. van Houdt MD, PhD, Dirk Strauss MD, PhD, Yvonne Schrage MD, PhD, Andrew J. Hayes MD, PhD, Chandrajit P. Raut MD, PhD, Mark Fairweather MD, PhD, Elizabeth H. Baldini MD, PhD, Alessandro Gronchi MD, PhD, Laura De Rosa MD, PhD, Anthony M. Griffin MD, PhD, Peter C. Ferguson MD, PhD, Jay Wunder MD, PhD, Michiel A. J. van de Sande MD, PhD, Augustinus D. G. Krol MD, PhD, Jacus Skoczylas MD, PhD, Claudia Sangalli MD, PhD, Silvia Stacchiotti MD, PhD,

Cancer Volume 126, Issue 13
First published: 21 April 2020

Abstract
Original Article
Free Access

free

Patient and diagnostic intervals of survivors of sarcoma: Results from the SURVSARC study

Vicky L. M. N. Soomers MD, Olga Husson PhD, Ingrid M. E. Desar MD, PhD, Michiel A. J. van de Sande MD, PhD, Jacco J. de Haan MD, PhD, Cornelis Verhoef MD, PhD, Ingeborg J. H. Vriens MD, Winan J. van Houdt MD, PhD, Lonneke van de Poll-Franse PhD, Winette T. A. van der Graaf MD, PhD,

Cancer Volume 126, Issue 24
First published: 01 October 2020

Abstract
Original Article
Open Access

oa

Long-term outcomes of pexidartinib in tenosynovial giant cell tumors

Hans Gelderblom MD, Andrew J. Wagner MD, PhD, William D. Tap MD, Emanuela Palmerini MD, PhD, Zev A. Wainberg MD, Jayesh Desai MBBS, John H. Healey MD, Michiel A. J. van de Sande MD, PhD, Nicholas M. Bernthal MD, Eric L. Staals MD, PhD, Charles G. Peterfy MD, PhD, Anna Maria Frezza MD, Henry H. Hsu MD, Qiang Wang PhD, Dale E. Shuster PhD, Silvia Stacchiotti MD,

Cancer Volume 127, Issue 6
First published: 16 November 2020

Abstract
ORIGINAL ARTICLE
Open Access

oa

Impaired social functioning in adolescent and young adult sarcoma survivors: Prevalence and risk factors

Cas Drabbe MD, Elena S. Coenraadts MD, Winan J. van Houdt MD, PhD, Michiel A. J. van de Sande MD, PhD, Johannes J. Bonenkamp MD, PhD, Jacco J. de Haan MD, PhD, Johanna W. M. Nin MD, PhD, Cornelis Verhoef MD, PhD, Winette T. A. van der Graaf MD, PhD, Olga Husson PhD,

Cancer Volume 129, Issue 9
First published: 14 February 2023

Abstract
RESEARCH ARTICLE
Open Access

oa

A novel colony-stimulating factor 1 (CSF1) translocation involving human endogenous retroviral element in a tenosynovial giant cell tumor

Astrid Lipplaa, Debora Meijer, Michiel A. J. van de Sande, Hans Gelderblom, Judith V. M. G. Bovée, Hailiang Mei, Karoly Szuhai,

Genes, Chromosomes and Cancer Volume 62, Issue 4
First published: 12 December 2022

Abstract
RESEARCH ARTICLE
Open Access

oa

The Variable Genomic Landscape During Osteosarcoma Progression: Insights From a Longitudinal WGS Analysis

Debora M. Meijer, Dina Ruano, Inge H. Briaire-de Bruijn, Pauline M. Wijers-Koster, Michiel A. J. van de Sande, Hans Gelderblom, Anne-Marie Cleton-Jansen, Noel F. C. C. de Miranda, Marieke L. Kuijjer, Judith V. M. G. Bovée,

Genes, Chromosomes and Cancer Volume 63, Issue 7
First published: 18 July 2024

Abstract
Research Article
Open Access

oa

Coxa Vara Deformity in Fibrous Dysplasia/McCune-Albright Syndrome: Prevalence, Natural History and Risk Factors: A Two-Center Study

Maartje E. Meier, Natasha M. Appelman-Dijkstra, Michael T. Collins, Raya E.S. Geels, Robert P. Stanton, Pieter Bas de Witte, Alison M. Boyce, Michiel A.J. van de Sande,

Journal of Bone and Mineral Research Volume 38, Issue 7
First published: 27 April 2023

Abstract
MELANOMA/SARCOMA
Open Access

oa

External validation and adaptation of a dynamic prediction model for patients with high-grade extremity soft tissue sarcoma

Anja J. Rueten-Budde PhD, Veroniek M. van Praag MD, Michiel A. J. van de Sande MD, PhD, Marta Fiocco PhD, PERSARC Study Group,

Journal of Surgical Oncology Volume 123, Issue 4
First published: 17 December 2020

Abstract
ORTHOPEDICS
Open Access

oa

Surgical management of 144 diffuse-type TGCT patients in a single institution: A 20-year cohort study

Geert Spierenburg MD, Lizz van der Heijden MD, PhD, Monique J. L. Mastboom MD, PhD, Kirsten van Langevelde MD, PhD, Robert J. P. van der Wal MD, PhD, Hans Gelderblom MD, PhD, Michiel A. J. van de Sande MD, PhD,

Journal of Surgical Oncology Volume 126, Issue 6
First published: 23 June 2022

Abstract
REVIEW ARTICLE
Open Access

oa

Multimodal management of tenosynovial giant cell tumors (TGCT) in the landscape of new druggable targets

Lizz van der Heijden MD, PhD, Geert Spierenburg, Joseph K. Kendal MD, MSc, Nicholas M. Bernthal MD, Michiel A. J. van de Sande MD, PhD,

Journal of Surgical Oncology Volume 128, Issue 3
First published: 04 August 2023
Collections: Emerging Innovations and Advancements in the Field of Musculoskeletal Oncology

Abstract
Original Article
Open Access

oa

Does CSF1 overexpression or rearrangement influence biological behaviour in tenosynovial giant cell tumours of the knee?

Monique J L Mastboom, Daisy M Hoek, Judith V M G Bovée, Michiel A J van de Sande, Károly Szuhai,

Histopathology Volume 74, Issue 2
First published: 28 August 2018

Abstract
Sarcoma
Free Access

free

The Clinical Approach Toward Giant Cell Tumor of Bone

Lizz van der Heijden, P.D. Sander Dijkstra, Michiel A.J. van de Sande, Judith R. Kroep, Remi A. Nout, Carla S.P. van Rijswijk, Judith V.M.G. Bovée, Pancras C.W. Hogendoorn, Hans Gelderblom,

The Oncologist Volume 19, Issue 5
First published: 09 April 2014

Abstract
Letter to the Editor
Free Access

free

In Reply

Lizz van der Heijden, P.D. Sander Dijkstra, Michiel A.J. van de Sande, Judith R. Kroep, Remi A. Nout, Carla S.P. van Rijswijk, Judith V.M.G. Bovée, Pancras C.W. Hogendoorn, Hans Gelderblom,

The Oncologist Volume 19, Issue 11
First published: 17 October 2014
Sarcomas
Open Access

oa

Single-Center Experience with Ifosfamide Monotherapy as Second-Line Treatment of Recurrent/Metastatic Osteosarcoma

Arie Jan Verschoor, Frank M. Speetjens, P.D. Sander Dijkstra, Marta Fiocco, Michiel A.J. van de Sande, Judith V.M.G. Bovée, Hans Gelderblom,

The Oncologist Volume 25, Issue 4
First published: 19 December 2019
Collections: The Oncologist in Europe

Abstract

Applied Filters

Filters

refine search

Refine Search

Search History

Saved Searches

free

Outcome of advanced, unresectable conventional central chondrosarcoma

Abstract

oa

Extrameningeal solitary fibrous tumors—surgery alone or surgery plus perioperative radiotherapy: A retrospective study from the global solitary fibrous tumor initiative in collaboration with the Sarcoma Patients EuroNet

Abstract

free

Patient and diagnostic intervals of survivors of sarcoma: Results from the SURVSARC study

Abstract

oa

Long-term outcomes of pexidartinib in tenosynovial giant cell tumors

Abstract

oa

Impaired social functioning in adolescent and young adult sarcoma survivors: Prevalence and risk factors

Abstract

oa

A novel colony-stimulating factor 1 (CSF1) translocation involving human endogenous retroviral element in a tenosynovial giant cell tumor

Abstract

oa

The Variable Genomic Landscape During Osteosarcoma Progression: Insights From a Longitudinal WGS Analysis

Abstract

oa

Coxa Vara Deformity in Fibrous Dysplasia/McCune-Albright Syndrome: Prevalence, Natural History and Risk Factors: A Two-Center Study

Abstract

oa

External validation and adaptation of a dynamic prediction model for patients with high-grade extremity soft tissue sarcoma

Abstract

oa

Surgical management of 144 diffuse-type TGCT patients in a single institution: A 20-year cohort study

Abstract

oa

Multimodal management of tenosynovial giant cell tumors (TGCT) in the landscape of new druggable targets

Abstract

oa

Does CSF1 overexpression or rearrangement influence biological behaviour in tenosynovial giant cell tumours of the knee?

Abstract

free

The Clinical Approach Toward Giant Cell Tumor of Bone

Abstract

free

In Reply

oa

Single-Center Experience with Ifosfamide Monotherapy as Second-Line Treatment of Recurrent/Metastatic Osteosarcoma

Abstract

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

Applied Filters

Filters

Publication Type

Publication Date

Access Status

Subjects

Published in

Author

Search Results

refine search

Refine Search

Search History

Saved Searches

Download PDFs

free Outcome of advanced, unresectable conventional central chondrosarcoma

oa Extrameningeal solitary fibrous tumors—surgery alone or surgery plus perioperative radiotherapy: A retrospective study from the global solitary fibrous tumor initiative in collaboration with the Sarcoma Patients EuroNet

free Patient and diagnostic intervals of survivors of sarcoma: Results from the SURVSARC study

oa Long-term outcomes of pexidartinib in tenosynovial giant cell tumors

oa Impaired social functioning in adolescent and young adult sarcoma survivors: Prevalence and risk factors

oa A novel colony-stimulating factor 1 (CSF1) translocation involving human endogenous retroviral element in a tenosynovial giant cell tumor

oa The Variable Genomic Landscape During Osteosarcoma Progression: Insights From a Longitudinal WGS Analysis

oa Coxa Vara Deformity in Fibrous Dysplasia/McCune-Albright Syndrome: Prevalence, Natural History and Risk Factors: A Two-Center Study

oa External validation and adaptation of a dynamic prediction model for patients with high-grade extremity soft tissue sarcoma

oa Surgical management of 144 diffuse-type TGCT patients in a single institution: A 20-year cohort study

oa Multimodal management of tenosynovial giant cell tumors (TGCT) in the landscape of new druggable targets

oa Does CSF1 overexpression or rearrangement influence biological behaviour in tenosynovial giant cell tumours of the knee?

free The Clinical Approach Toward Giant Cell Tumor of Bone

free In Reply

oa Single-Center Experience with Ifosfamide Monotherapy as Second-Line Treatment of Recurrent/Metastatic Osteosarcoma

free

Outcome of advanced, unresectable conventional central chondrosarcoma

oa

Extrameningeal solitary fibrous tumors—surgery alone or surgery plus perioperative radiotherapy: A retrospective study from the global solitary fibrous tumor initiative in collaboration with the Sarcoma Patients EuroNet

free

Patient and diagnostic intervals of survivors of sarcoma: Results from the SURVSARC study

oa

Long-term outcomes of pexidartinib in tenosynovial giant cell tumors

oa

Impaired social functioning in adolescent and young adult sarcoma survivors: Prevalence and risk factors

oa

A novel colony-stimulating factor 1 (CSF1) translocation involving human endogenous retroviral element in a tenosynovial giant cell tumor

oa

The Variable Genomic Landscape During Osteosarcoma Progression: Insights From a Longitudinal WGS Analysis

oa

Coxa Vara Deformity in Fibrous Dysplasia/McCune-Albright Syndrome: Prevalence, Natural History and Risk Factors: A Two-Center Study

oa

External validation and adaptation of a dynamic prediction model for patients with high-grade extremity soft tissue sarcoma

oa

Surgical management of 144 diffuse-type TGCT patients in a single institution: A 20-year cohort study

oa

Multimodal management of tenosynovial giant cell tumors (TGCT) in the landscape of new druggable targets

oa

Does CSF1 overexpression or rearrangement influence biological behaviour in tenosynovial giant cell tumours of the knee?

free

The Clinical Approach Toward Giant Cell Tumor of Bone

free

In Reply

oa

Single-Center Experience with Ifosfamide Monotherapy as Second-Line Treatment of Recurrent/Metastatic Osteosarcoma